Hide metadata

dc.contributor.authorJohannessen, Asgeir
dc.contributor.authorNaman, Ezra
dc.contributor.authorNgowi, Bernard J
dc.contributor.authorSandvik, Leiv
dc.contributor.authorMatee, Mecky I
dc.contributor.authorAglen, Henry E
dc.contributor.authorGundersen, Svein G
dc.contributor.authorBruun, Johan N
dc.date.accessioned2015-10-09T02:10:45Z
dc.date.available2015-10-09T02:10:45Z
dc.date.issued2008
dc.identifier.citationBMC Infectious Diseases. 2008 Apr 22;8(1):52
dc.identifier.urihttp://hdl.handle.net/10852/46675
dc.description.abstractBackground Studies of antiretroviral therapy (ART) programs in Africa have shown high initial mortality. Factors contributing to this high mortality are poorly described. The aim of the present study was to assess mortality and to identify predictors of mortality in HIV-infected patients starting ART in a rural hospital in Tanzania. Methods This was a cohort study of 320 treatment-naïve adults who started ART between October 2003 and November 2006. Reliable CD4 cell counts were not available, thus ART initiation was based on clinical criteria in accordance with WHO and Tanzanian guidelines. Kaplan-Meier models were used to estimate mortality and Cox proportional hazards models to identify predictors of mortality. Results Patients were followed for a median of 10.9 months (IQR 2.9–19.5). Overall, 95 patients died, among whom 59 died within 3 months of starting ART. Estimated mortality was 19.2, 29.0 and 40.7% at 3, 12 and 36 months, respectively. Independent predictors of mortality were severe anemia (hemoglobin <8 g/dL; adjusted hazard ratio [AHR] 9.20; 95% CI 2.05–41.3), moderate anemia (hemoglobin 8–9.9 g/dL; AHR 7.50; 95% CI 1.77–31.9), thrombocytopenia (platelet count <150 × 109/L; AHR 2.30; 95% CI 1.33–3.99) and severe malnutrition (body mass index <16 kg/m2; AHR 2.12; 95% CI 1.06–4.24). Estimated one year mortality was 55.2% in patients with severe anemia, compared to 3.7% in patients without anemia (P < 0.001). Conclusion Mortality was found to be high, with the majority of deaths occurring within 3 months of starting ART. Anemia, thrombocytopenia and severe malnutrition were strong independent predictors of mortality. A prognostic model based on hemoglobin level appears to be a useful tool for initial risk assessment in resource-limited settings.
dc.language.isoeng
dc.rightsJohannessen et al.
dc.rightsAttribution 2.0 Generic
dc.rights.urihttp://creativecommons.org/licenses/by/2.0/
dc.titlePredictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania
dc.typeJournal article
dc.date.updated2015-10-09T02:10:46Z
dc.creator.authorJohannessen, Asgeir
dc.creator.authorNaman, Ezra
dc.creator.authorNgowi, Bernard J
dc.creator.authorSandvik, Leiv
dc.creator.authorMatee, Mecky I
dc.creator.authorAglen, Henry E
dc.creator.authorGundersen, Svein G
dc.creator.authorBruun, Johan N
dc.identifier.doihttp://dx.doi.org/10.1186/1471-2334-8-52
dc.identifier.urnURN:NBN:no-50856
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/46675/1/12879_2007_Article_643.pdf
dc.type.versionPublishedVersion
cristin.articleid52


Files in this item

Appears in the following Collection

Hide metadata

Attribution 2.0 Generic
This item's license is: Attribution 2.0 Generic